Rigel Pharmaceuticals Inc banner

Rigel Pharmaceuticals Inc
NASDAQ:RIGL

Watchlist Manager
Rigel Pharmaceuticals Inc Logo
Rigel Pharmaceuticals Inc
NASDAQ:RIGL
Watchlist
Price: 34.47 USD -0.43% Market Closed
Market Cap: $625.6m

Wall Street
Price Targets

RIGL Price Targets Summary
Rigel Pharmaceuticals Inc

Wall Street analysts forecast RIGL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RIGL is 47.94 USD with a low forecast of 24.24 USD and a high forecast of 74.55 USD.

Lowest
Price Target
24.24 USD
30% Downside
Average
Price Target
47.94 USD
39% Upside
Highest
Price Target
74.55 USD
116% Upside
Rigel Pharmaceuticals Inc Competitors:
Price Targets
PAYS
Paysign Inc
172% Upside
UFPT
UFP Technologies Inc
17% Upside
FLB
Fluidigm Corp
25% Upside
SUPN
Supernus Pharmaceuticals Inc
22% Upside

Revenue
Forecast

32% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
32% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 13 years the compound annual growth rate for Rigel Pharmaceuticals Inc's revenue is 32%. The projected CAGR for the next 4 years is 22%.

Operating Income
Forecast

N/A
Past Growth
58% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
N/A
Past Growth
58% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

The compound annual growth rate of Rigel Pharmaceuticals Inc's operating income for the next 4 years is 58%.

Net Income
Forecast

N/A
Past Growth
51% / Year
Estimated Growth
Estimates Accuracy
-28%
Average Miss
N/A
Past Growth
51% / Year
Estimated Growth
Estimates Accuracy
-28%
Average Miss

The compound annual growth rate of Rigel Pharmaceuticals Inc's net income for the next 4 years is 51%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RIGL's stock price target?
Price Target
47.94 USD

According to Wall Street analysts, the average 1-year price target for RIGL is 47.94 USD with a low forecast of 24.24 USD and a high forecast of 74.55 USD.

What is Rigel Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
22%

For the last 13 years the compound annual growth rate for Rigel Pharmaceuticals Inc's revenue is 32%. The projected CAGR for the next 4 years is 22%.

What is Rigel Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
58%

The compound annual growth rate of Rigel Pharmaceuticals Inc's operating income for the next 4 years is 58%.

What is Rigel Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
51%

The compound annual growth rate of Rigel Pharmaceuticals Inc's net income for the next 4 years is 51%.

Back to Top